Spyre Therapeutics
SYRE
SYRE
54 hedge funds and large institutions have $601M invested in Spyre Therapeutics in 2023 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
54
Holders Change
+25
Holders Change %
+86.21%
% of All Funds
0.79%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
29
Increased
16
Reduced
5
Closed
4
Calls
$44K
Puts
–
Net Calls
+$44K
Net Calls Change
+$11K
Top Buyers
1 |
![]()
1
Fidelity Investments
Boston,
Massachusetts
|
$79.7M |
2 |
PA
2
Perceptive Advisors
New York
|
$56.1M |
3 |
RI
3
RTW Investments
New York
|
$48M |
4 |
VA
4
VR Adviser
New York
|
$51.1M |
5 |
DTC
5
Deep Track Capital
Greenwich,
Connecticut
|
$42M |